Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04641728 | Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer | unknown | Phase 2 | 28 | Saitama Medical University International Medical CenterOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT04796467 | 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients | unknown | Phase 2 / Phase 3 | 50 | Peking Union Medical College HospitalOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05258526 | Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study)(BENEFIT-CA) | unknown | N/A | 80 | Hospital de Clinicas de Porto AlegreOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05493319 | Hypopressive Exercise Associated With Strength and Resistance Training in Women Treated for Gynecological Cancer | unknown | N/A | 36 | Universidade Federal de Sao CarlosOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT04995731 | Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer | unknown | — | 328 | Assiut UniversityOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT03692663 | Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer | unknown | Early Phase 1 | 9 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 1, 2022 | clinicaltrials |
| NCT05481372 | PINPOINT Feasibility Study | unknown | N/A | 14 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT05017181 | Novel MRI Assessment of Prostate Cancer VALIDATE-PRO(VALIDATE-PRO) | unknown | — | 234 | University College, LondonOTHER | 1 | Jul 29, 2022 | clinicaltrials |
| NCT05179317 | Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer | unknown | Phase 2 | 60 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 29, 2022 | clinicaltrials |
| NCT05479487 | Fluzoparib and Apatinib Versus Fluzoparib in Relapsed Ovarian Carcinoma Maintenance Treatment | unknown | Phase 2 | 132 | Xiaohua Wu MDOTHER | 0 | Jul 29, 2022 | clinicaltrials |
| NCT04903665 | PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I | unknown | — | 495 | Fudan UniversityOTHER | 1 | Jul 28, 2022 | clinicaltrials |
| NCT05475847 | Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer(TIL) | unknown | Phase 1 | 20 | Fudan UniversityOTHER | 1 | Jul 28, 2022 | clinicaltrials |
| NCT02562365 | Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer(ACTS) | unknown | Phase 2 | 130 | Xiaohua Wu MDOTHER | 1 | Jul 27, 2022 | clinicaltrials |
| NCT04845425 | Analysis of miRNA Expression in Endometrial Cancer(MIRCE) | unknown | — | 150 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT05467319 | Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS(FORGE) | unknown | Phase 3 | 82 | Alberta Health Services, CalgaryOTHER | 0 | Jul 20, 2022 | clinicaltrials |
| NCT04996602 | Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT05247619 | A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer | unknown | Phase 2 | 49 | Zhejiang Cancer HospitalOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT05455736 | STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational Study(STARR) | unknown | — | 90 | Azienda Ospedaliero-Universitaria CareggiOTHER | 1 | Jul 13, 2022 | clinicaltrials |
| NCT05444374 | A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer | unknown | Phase 2 | 48 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT03827837 | Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors | unknown | Phase 2 | 265 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05122221 | CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers | unknown | Phase 1 | 12 | Corregene Biotechnology Co., LtdINDUSTRY | 1 | Jun 28, 2022 | clinicaltrials |
| NCT05427864 | Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging | unknown | N/A | 47 | Gulhane Training and Research HospitalOTHER_GOV | 1 | Jun 28, 2022 | clinicaltrials |
| NCT05430737 | A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer | unknown | N/A | 60 | West China HospitalOTHER | 1 | Jun 24, 2022 | clinicaltrials |
| NCT04116775 | Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. | unknown | Phase 2 | 32 | Julie Graff, MDFED | 1 | Jun 23, 2022 | clinicaltrials |
| NCT03284151 | Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma | unknown | — | 26 | Centre Francois Baclesse, LuxembourgOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT04864431 | Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian Cancer(VitD) | unknown | N/A | 54 | Indonesia UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05252806 | Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer(QmpMRI) | unknown | — | 30 | Radboud University Medical CenterOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05078359 | Optimizing Positive Predicting Value of Prostate MRI(PROMOD) | unknown | — | 5,000 | Ospedali Riuniti di FoggiaOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05422183 | Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer | unknown | Phase 2 | 20 | Zhongda HospitalOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT03588819 | Stereotactic MRI-Guided Radiation for Localized Prostate Cancer(2SMART) | unknown | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Jun 14, 2022 | clinicaltrials |
| NCT05410015 | Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer | unknown | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT05410028 | New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence | unknown | — | 1,000 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT04278261 | Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer | unknown | N/A | 216 | Shanghai East HospitalOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT04982146 | Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei | unknown | Phase 1 | 10 | Maimónides Biomedical Research Institute of CórdobaOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05387460 | Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer | unknown | — | 2,000 | Tongji HospitalOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05385068 | A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi(t) | unknown | Phase 2 | 35 | Peking Union Medical College HospitalOTHER | 0 | May 23, 2022 | clinicaltrials |
| NCT05382182 | Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021 | unknown | — | 100 | Sohag UniversityOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT04718987 | Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate Brachytherapy(PRIAPUS) | unknown | N/A | 10 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT05187949 | Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer(PROSHADE) | unknown | — | 1,781 | Universidad Miguel Hernandez de ElcheOTHER | 0 | May 17, 2022 | clinicaltrials |
| NCT05375526 | Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer | unknown | N/A | 10 | Maastricht University Medical CenterOTHER | 1 | May 16, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT03780075 | Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 | 50 | Peking Union Medical College HospitalOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05371301 | Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT04854343 | SLPI for Prostate Cancer | unknown | — | 280 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03235687 | Decision Impact Trial of the ExoDx Prostate (IntelliScore) | unknown | N/A | 1,000 | Exosome Diagnostics, Inc.INDUSTRY | 1 | May 6, 2022 | clinicaltrials |
| NCT04251546 | Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV | unknown | — | 80 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT04856306 | Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L(Magical) | unknown | — | 300 | Medstar Health Research InstituteOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT04866394 | Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS(SPARTACUS) | unknown | N/A | 40 | Sunnybrook Health Sciences CentreOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05362669 | SMS Messaging for Invitation in the Cervical Cancer Screening Programme(CERCA-SMS) | unknown | N/A | 450 | Institut Català d'OncologiaOTHER | 1 | May 5, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Aug 9, 2022source: clinicaltrials